Hyphens Pharma Introduces Novel Acne Treatment in Singapore, Malaysia; Shares Up Nearly 2%
I'm PortAI, I can summarize articles.
Hyphens Pharma , through Hyphens Pharma International, launched Winlevi (clascoterone) cream 1% in Singapore and Malaysia, according to a Thursday filing with the Singapore Exchange. Shares of the company were up nearly 2% in recent trading. The launch comes after the company entered into an exclusive license and supply agreement with Cosmo Pharmaceuticals subsidiary Cassiopea. The acne cream provides treatment for acne-related inflammation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments